Le Lézard
Classified in: Science and technology
Subjects: Photo/Multimedia, Personnel

Align Appoints Chris Zadrima to Chief Operating Officer


Align, the leading global provider of Technology Infrastructure Solutions and Managed IT Services, is pleased to announce the appointment of Chris Zadrima as Chief Operating Officer (COO). In his previous role as a managing director, Chris oversaw all aspects of Align's managed services practice including client support, cloud architecture and strategy, project management, network operations center, and IT service desk.

Zadrima's strong financial background, proven track record in optimizing operations, and his impact on customer success will be instrumental in driving Align's continued expansion and securing its position as an industry leader across its solutions?Workplace Technology, Data Center Design and Build, Migrations, and Managed Services.

Chris expressed his enthusiasm for assuming the role, "I am excited and honored to serve as Chief Operating Officer at Align. I have dedicated my career to the improvement of operations and service delivery and fostering a culture of innovation. I will continue to focus on how our systems, tools, processes, and organizational structure deliver quality services to our client base."

With over 17 years of experience, Chris stands as a distinguished leader in the industry and was recently honored by CRN, a division of The Channel Company, as one of the 2023 Next-Gen Solution Provider Leaders. This prestigious accolade underscores individuals who positively impact their companies' trajectories and exhibit the potential to emerge as future leaders.

"Chris is perfectly positioned to steer Align toward operational excellence as our COO. With his tenure of 10 years at Align overseeing our professional and managed IT service divisions, he will continue to improve and automate our tools and project delivery. Chris brings a wealth of experience to elevate Align's performance," stated Jim Dooling, CEO of Align. "I'm excited to see the future of Align under Chris' leadership?a future where his talents are applied across our entire organization."

About Align

Align is a premier global provider of technology infrastructure solutions. For over 36 years, leading firms worldwide have relied on Align to guide them through IT challenges, delivering complete, secure solutions for business change and growth. Align is headquartered in Dallas, Texas and has offices in New York City, London, Chicago, San Francisco, Arizona, New Jersey, Texas and Virginia.

To learn more about Align, visit our website here: https://www.align.com/ and follow Align on LinkedIn and at @AlignITAdvisor on Twitter.


These press releases may also interest you

at 00:00
XSOOH has always been at the forefront of hair care innovation, striving to deliver cutting-edge  products  that enhance the way customers achieve their desired looks. In a world where time is precious, XSOOH  proudly announces the launch of the...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...

3 jui 2024
On June 29, the "Gather Great Wisdom to Shape the Future of Intelligent Manufacturing?Special Exhibition on Design Intelligence and High Quality Development", hosted by the China Academy of Art (CAA), opened at the National Museum of China in...

3 jui 2024
Intermap Technologies ("Intermap" or the "Company"), a global leader in 3D geospatial products and intelligence solutions, announces a new financing. The Company is offering up to a maximum of 4,300,000 Class "A" common shares of the Company...

3 jui 2024
"The Classic Quotes by Xi Jinping," a multilingual TV show produced by China Media Group, aired in Kazakhstan on Tuesday after Chinese...

3 jui 2024
Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in discovering, developing and commercializing both first-in-class and best-in-class therapies for hematological malignancies, announced today that on July 2, 2024, in relation to...



News published on and distributed by: